Human Reproductive and Stem Cells Bank Services Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Page: 215 | Report Code: LS24081601 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

The global market value of the Human Reproductive and Stem Cells Bank Services market was valued at USD 9.8 billion in 2022, and a CAGR of 7.1% is expected during the forecast period. Increasing demand for stem cell transplantation and demand for safe and reliable sources of stem cells have increased. Increasing investment by private companies in stem cell research is driving growth in the market significantly.

Improvements in stem cell isolation, storage, and technologies are driving growth in the market. General, public, and medical experts are becoming more aware of the advantages of stem-cell banking, such as its ability to treat a variety of illnesses, which is driving growth in the market significantly. The rise in the number of people with diabetes is driving growth in the market.


Growth Drivers

Rising rates of infertility due to factors like lifestyle changes, stress, environmental pollutants, and delayed childbearing had increased the demand for reproductive services, including IVF and other assisted reproductive technologies. Advances in cryopreservation techniques, genetic screening, and stem-cell therapies have made these services more effective, accessible, and reliable, thus boosting market growth. Ongoing research and development in stem-cell therapies for treating a variety of diseases, including cancer, neurogenerative disorders, and auto-immune diseases, are driving demand for the stem cell banking services market significantly.

Growing awareness about the benefits of stem cell banking and the availability of reproductive services is leading to greater acceptance and adoption. Initiatives by healthcare providers and the government to educate people about the potential of these services are driving growth in the market significantly. The aging population is increasing the demand for stem-cell therapies, particularly in the treatment of age-related conditions, which in turn boosts the market for stem-cell banking.

Countries with advanced medical infrastructure and affordable pricing for reproductive and stem cell therapies are attracting patients from around the world, which is fueling the market growth. Increasing disposable income, particularly in developing regions, will allow more individuals and couples to afford reproductive services and stem-cell banking. Entry of private companies into the market is enhancing service quality, accessibility, and innovation, thereby driving growth. Collaboration between research institutions, hospitals, and biotech companies is leading to significant advancements in reproductive and stem cell services. Expanding range of application for stem cells in treating chronic diseases, regenerative medicines, and personalizing medicine is driving demand for stem cell banking services. The growing prevalence of cardiovascular diseases and blood-related issues is driving growth in the market significantly.

Segmentation

By Utilization

·         Used

·         Unused

By Bank Type

·         Public

·         Private

By Service Type

·         Collection and Transportation

·         Processing

·         Analysis

·         Storage

By Cell Type

·         Cord-Blood

·         Cord-Tissue

·         Placenta

·         Adult Stem-Cell

·         Embryonic Stem-Cell

·         Umbilical Cord-Stem Cell

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Human Reproductive and Stem Cell Banking Services Market by Bank Type

On the basis of the bank type, the human reproductive stem cell banking services market is segmented into public and private. Private banking is the leading segment and is expected to drive growth in the market during the forecast period, as most of the families store their stems in private banks for future use. This kind of bank provides health insurance for an infected person who is treated with the help of stem cells. This kind of bank is well-known for providing premium services, which would drive the growth in the market significantly.


Increased incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases is driving growth in the market significantly. Public banking, on the other hand, allows anyone in need to access stem cells without a direct cost; donated stem cells are available to the public and are matched with patients requiring transplants. There is no cost to donate to a public bank. Stem cells stored in public banks are often used in research and development and are contributing to advancements in medical science.

Regional Outlook

On the basis of the regions, the market is segmented into 5 parts: Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America is the leading segment and is expected to dominate the market during the forecast period due to the growing prevalence of chronic diseases and increasing investment in healthcare infrastructure, due to which the United States and Canada are the leading segments in the market. Genetic problems and other reproduction-related disorders are at the highest rate in the region; an increasing geriatric population and growing awareness among all about the importance of stem-cell therapies are driving the growth in the market significantly.

The presence of key players in the region is one of the key reasons behind the significant growth in the market. The European market is also witnessing significant growth in countries like Germany, France, the UK, Greece, Russia, and Turkey due to the increasing geriatric population in the region. Growing development of advanced storage devices in the region and the presence of key players in the market are driving growth in the region. Ireland, Sweden, Finland, and Belgium are among the countries investing significant amounts in research and development during the forecast period.

Growing adoption of medical advancements in the Asia Pacific region, especially in countries like China, India, Japan, South Korea, and Vietnam, is driving the growth in the market. The increasing geriatric population in the region is driving the demand for stem-cell therapies in the market significantly. Increased incidences of chronic illnesses such as cancer, cardiac issues, and diabetes are driving growth in the market significantly. Future stem cell banking market expansion is driving growth in the market.

The presence of key players is the reason behind the sheer dominance of the region in this market. Rising rates of infertility due to a growing population is the key reason behind the significant growth in the market. Increasing disposable income and rising urbanization are the key reasons behind the significant growth in the market. Middle East and Africa, and Latin America is witnessing significant growth in the market.


 Key Players

·         Global Cord blood Corporation

·         Cordlife Group Limited

·         Cryo-cell international Inc.

·         Brain-storm Cell Ltd.

·         Life cell international private Ltd.

·         Smart Cell International Ltd.

·         Viacord, LLC

·         CBR System Inc.

·         Other Players

Buy Report